- Board Change
- Results of AGM
- Positive FDA Feedback to Progress Bexmarilimab
- Notice of Faron Pharmaceuticals Ltd’s AGM
- Faron´s Annual Report 2022 Published
- Financial Statement January 1 to December 31 2022
- Update to Faron’s Financial Calendar for 2023
- Notice of 2022 Full-Year Results and Annual Report
- Holding(s) in Company
- Results of Placing
More ▼
Key statistics
On Friday, Faron Pharmaceuticals Oy (FARN:LSE) closed at 315.00, -20.25% below its 52-week high of 395.00, set on Dec 07, 2022.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 315.00 |
---|---|
High | 310.00 |
Low | 310.00 |
Bid | 305.00 |
Offer | 335.00 |
Previous close | 310.00 |
Average volume | 8.19k |
---|---|
Shares outstanding | 63.50m |
Free float | 34.22m |
P/E (TTM) | -- |
Market cap | 200.83m GBP |
EPS (TTM) | -0.4596 GBP |
Data delayed at least 20 minutes, as of Mar 24 2023 13:53 BST.
More ▼